Ionis Pharmaceuticals IONS Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's change in inventories?
- Ionis Pharmaceuticals (IONS) reported change in inventories of -$338K in Q1 2026.
- How has Ionis Pharmaceuticals's change in inventories changed year-over-year?
- Ionis Pharmaceuticals's change in inventories increased by 66.5% year-over-year, from -$1.01M to -$338K.
- What is the long-term trend for Ionis Pharmaceuticals's change in inventories?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's change in inventories has grown at a 86.0% compound annual growth rate (CAGR), from $4.22M to $14.6M.
- What does change in inventories mean?
- The net change in the value of goods held in stock during the period.
- How do you interpret change in inventories?
- A decrease is generally positive for cash flow, while a large increase consumes cash and may signal slowing demand.
- How does change in inventories compare across companies?
- Standard working capital metric; peers in manufacturing or biotech will show varying levels based on their production cycles.